What is the current price / NAV of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The current NAV of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) is ₹22.32, as of 9th March 2026.What are the returns of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) was launched on 10th July 2019. This mutual fund's past returns are as follows:- 1 Year Returns: 4.59%
- 3 Year Returns: 17.27%
- 5 Year Returns: 8.26%
What are the top 5 sectoral holdings of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The top sectors Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) has invested in are as follows:- Pharmaceuticals | 76.60%
- Labs & Life Sciences Services | 19.90%
- Investment Banking & Brokerage | 1.57%
- Others | 1.12%
- Diversified Chemicals | 0.81%
What are the top 5 holdings of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The top 5 holdings for Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) are as follows:- Sun Pharmaceutical Industries Ltd | 13.34%
- Apollo Hospitals Enterprise Ltd | 7.78%
- Torrent Pharmaceuticals Ltd | 5.20%
- J B Chemicals and Pharmaceuticals Ltd | 4.99%
- Ajanta Pharma Ltd | 4.53%
What is the asset allocation of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The asset allocation for Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) is as follows:- Equity | 98.45%
- Cash & Equivalents | 1.55%
What is the AUM of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The AUM (i.e. assets under management) of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) is ₹854.04 Cr as of 9th March 2026.What is the expense ratio of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The expense ratio of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) Plan is 1.02 as of 9th March 2026.What is the alpha ratio of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The alpha ratio for the Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) is -25.47
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The volatility or standard deviation for the Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) is 12.83
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The Sharpe ratio for the Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) is 0.59
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The Sortino Ratio for the Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) is 0.06
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv)?
The PE ratio of Aditya Birla SL Pharma & Healthcare Fund(IDCW-Reinv) is 37.09, while category PE ratio is 40.86.

Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%